Carlo Pozzilli is Full Professor of Clinical
Neurology and Chief at the Multiple
Sclerosis Center of Ospedale S. Andrea,
at the University of Rome “La Sapienza”.
He gained his MD at the University of
Rome “La Sapienza” in 1979 and in 2000
became an Associate Professor, then
Professor Clinical Neurology in 2006. He
is a member of the European Committee
for Treatment and Research in Multiple
Sclerosis, the Italian Neurological Society
and the International Federation of
Multiple Sclerosis (International Medical
Advisory Board). He has participated as
first investigator in around 120 multicentre
clinical trials on patients with MS. Carlo
Pozzilli is author of 310 papers and editor
of several books on MS.
Disclosure of faculty relationships
Declared to be member of scientific advisory boards: Novartis, Merck Serono, Biogen Idec, Sanofi-Aventis, Genzyme, Almirall and Bayer Schering. He received funding and honoraria from Novartis, Merck Serono, Biogen Idec, Sanofi-Aventis, Genzyme, Almirall, Bayer Schering, Actelion, Teva. He received research support from Novartis, Merck Serono, Biogen Idec, Bayer Schering and Sanofi-Aventis.
